Li Ning Co Ltd (2331)
Hong Kong Stock Exchange · Hong Kong · prices in HKD · close of 21 Oct 2026
Key indicators
| Last close | HKD 12.90 |
|---|---|
| 52-week range | 12.04 – 22.36 |
| Return, 1 month / 3 months | +2.6% / −10.4% |
| Return, 1 year / 3 years | −20.2% / −57.9% |
| Trend | Below its 200-day average |
| RSI (14) | 52 |
| Volatility (1 year) | 33.6% |
| Worst drawdown (1 year) | -44.3% |
| Average daily value traded | 328.82M HKD |
| Dividend yield | 5.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Li Ning designs, develops and sells sportswear under its own brand, including athletic footwear, apparel and accessories for sports such as running, basketball, badminton and fitness. The company serves everyday consumers and sports enthusiasts through its own retail stores, franchised outlets and online channels, mainly in its home market of China. Li Ning is based in China and takes its name from the gymnast who founded the brand.
Li Ning Co Ltd trades under the code 2331 on the Hong Kong Stock Exchange in Hong Kong, with its price quoted in Hong Kong dollars (HKD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Li Ning Co Ltd (2331) trades on the Hong Kong Stock Exchange in Hong Kong. It last closed at HKD 12.90 on 21 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 1,154 of 2,611 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 20.2% and over the last three months it fell 10.4%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Hong Kong Stock Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 31 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -23.3% | ||
| From 52-week high | -41.3% | ||
| Momentum | 34 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -10.4% | ||
| 6-month return | -36.7% | ||
| 12-month return, skipping the last month | -22.2% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 33.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -44.3% | ||
| Liquidity | 96 · Strong | Trades actively. | |
| Average daily value traded | 328.82M HKD | ||
| Zero-volume days | 0.0% | ||
| Income | 56 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 5.2% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
Returns
| 1 week | +3.0% |
|---|---|
| 1 month | +2.6% |
| 3 months | −10.4% |
| 6 months | −36.7% |
| 1 year | −20.2% |
| 3 years | −57.9% |
| 5 years | – |
Signals
| 50-day / 200-day average | 13.05 / 16.83 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.40 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 3 Sep 2026 | HKD 0.4061 |
| 15 Jun 2026 | HKD 0.2686 |
| 3 Sep 2025 | HKD 0.3680 |
| 16 Jun 2025 | HKD 0.2266 |
| 29 Aug 2024 | HKD 0.4120 |
| 17 Jun 2024 | HKD 0.2036 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Hong Kong Stock Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.